[1]
D. Hasmono, S. Samirah, R. Hartono, M. Subkhan, M. A. Yoshida, and F. K. Leliga, “Safety outcomes of remdesivir for treatment of COVID-19 hospitalised patients in Indonesia”, Pharm Educ, vol. 24, no. 3, pp. p. 348–352, Jun. 2024.